Galera Therapeutics, Inc. announced it has received $15 million in funding from new investor Sofinnova Ventures, bringing its Series B financing total to $57 million. In connection with this financing, Mike Powell, PhD, General Partner at Sofinnova, will join the Galera Board of Directors.